IGF2 and Alzheimer disease: AD may include a vicious cycle of increasing pathogenic alterations and neurotrophic decline, as suggested by the observation that IGF2 attenuates Aβ-induced damage and that Aβ decreases IGF2 expression (Standridge, 2006).